Syndax Pharmaceuticals Inc

-0.13 (-0.59%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)1.49B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.6 Million
Adjusted EPS-$0.59
See more estimates
10-Day MA$22.18
50-Day MA$25.03
200-Day MA$23.15
See more pivots

Syndax Pharmaceuticals Inc Stock, NASDAQ:SNDX

35 Gatehouse Drive, Building D, Waltham, Massachusetts 02451
United States of America
Phone: +1.781.419.1400
Number of Employees: 107


Syndax Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company engaged in the development of cancer therapies. Its product candidates include SNDX-5613 and SNDX-6352. The company was founded by Richard A. Heyman, Eckard Weber, Peter Ordentlich, Ronald M. Evans and Michael Downes on October 11, 2005 and is headquartered in Waltham, MA.